Locations:
Search IconSearch

Brain Health

23-NEU-4390509-CQD-Hero-650×450

Microglial Immunometabolism Endophenotypes Implicated in Sex Differences in Alzheimer’s Disease

Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches

23-NEU-4357265-man-in-rural-setting-650×450
November 27, 2023/Neurosciences/Brain Health

Prospective Study Hints at Age-Related Memory Advantages for Rural Dwellers

For some older adults, a rural setting in late life may be protective

Elderly man waiting for CT scan
August 22, 2023/Behavioral Health

The Difficult, Essential Talk About Dementia

Patients benefit when doctors disclose with care

23-NEU-4028232-CQD-Hero-2-650×450

Study Suggests New NINDS Criteria May Identify Fighters at Risk of Chronic Traumatic Encephalopathy

Criteria-based diagnosis of traumatic encephalopathy syndrome predicts changes in brain volumes and cognition

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-NEU-3890311_alzheimers-in-women_650x450

Pilot Study to Target Sex-Based Differences in Alzheimer’s Disease

Plasma proteome analysis aimed at identifying candidate blood-based biomarkers in women

23-NEU-3739358-CQD-Hero-650×450

Markers of Metabolic Syndrome Linked to Cognitive Decline in MCI and Alzheimer’s

High plasma ApoA1 and TG/HDL-C ratio predict faster progression

23-NEU-3600025-165292944-CQD-Hero-650×450

New Cognitive Battery Reliably Screens for MCI, Early AD in Primary Care Setting

Self-administered tool can be completed in 10 minutes in waiting room

23-NEU-3559063_dementia_650x450
February 17, 2023/Neurosciences/Brain Health

Dementia With Initial Nonamnestic Symptoms Predicts Rapid Course

New findings have important implications for clinical trial design

22-NEU-3482371 Alzheimers-brain-650×450
January 12, 2023/Neurosciences/Brain Health

Does Peripheral Inflammation Drive Alzheimer’s Disease Progression?

New research explores the role of immune cell and blood-brain barrier changes

22-NEU-3452010_AI-in-brain-research_650x450

Deep Learning Framework Unveiled for Identifying Risk Genes and Drug Targets in Alzheimer’s Disease

Open-source artificial intelligence technology uses human genetic data to find candidate drugs

BackPage 2 of 4Next

Advertisement

Ad